Polymorphism in INSR Locus Modifies Risk of Atrial Fibrillation in Patients on Thyroid Hormone Replacement Therapy

AIMS: Atrial fibrillation (AF) is a risk for patients receiving thyroid hormone replacement therapy. No published work has focused on pharmacogenetics relevant to thyroid dysfunction and AF risk. We aimed to assess the effect of L-thyroxine on AF risk stratified by a variation in a candidate gene. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Soto-Pedre, Enrique, Siddiqui, Moneeza K., Maroteau, Cyrielle, Dawed, Adem Y., Doney, Alex S., Palmer, Colin N. A., Pearson, Ewan R., Leese, Graham P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260687/
https://www.ncbi.nlm.nih.gov/pubmed/34249083
http://dx.doi.org/10.3389/fgene.2021.652878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260687/
https://www.ncbi.nlm.nih.gov/pubmed/34249083
http://dx.doi.org/10.3389/fgene.2021.652878

Ejemplares similares